tiprankstipranks
Kane Biotech Inc (TSE:KNE)
TSXV:KNE
Canadian Market

Kane Biotech (KNE) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Kane Biotech Inc’s (KNE) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Kane Biotech Inc is a Buy.
Kane Biotech Inc’s (KNE) 20-Day exponential moving average is 0.14, while Kane Biotech Inc’s (KNE) share price is C$0.145, making it a Sell.
Kane Biotech Inc’s (KNE) 50-Day exponential moving average is 0.14, while Kane Biotech Inc’s (KNE) share price is C$0.145, making it a Buy.

Kane Biotech (KNE) Pivot Points

Jul 23, 2024, 11:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.14
0.14
0.14
0.14
0.14
0.14
0.14
Fibonacci
0.14
0.14
0.14
0.14
0.14
0.14
0.14
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Kane Biotech (KNE) Moving Averages

Jul 23, 2024, 11:19 PM
Period
Simple
Exponential
MA5
0.14Sell
0.14Sell
MA10
0.14Sell
0.14Sell
MA20
0.14Sell
0.14Sell
MA50
0.14Buy
0.14Buy
MA100
0.13Buy
0.13Buy
MA200
0.10Buy
0.11Buy
Kane Biotech Inc’s (KNE) 10-Day exponential moving average is 0.14, while Kane Biotech Inc’s (KNE) share price is C$0.145, making it a Sell.
Kane Biotech Inc’s (KNE) 100-Day exponential moving average is 0.13, while Kane Biotech Inc’s (KNE) share price is C$0.145, making it a Buy.
Kane Biotech Inc’s (KNE) stock price is C$0.145 and Kane Biotech Inc’s (KNE) 50-day simple moving average is 0.14, creating a Buy signal.
Kane Biotech Inc’s (KNE) stock price is C$0.145 and Kane Biotech Inc’s (KNE) 100-day simple moving average is 0.13, creating a Buy signal.
Kane Biotech Inc’s (KNE) stock price is C$0.145 and Kane Biotech Inc’s (KNE) 200-day simple moving average is 0.10, creating a Buy signal.

Kane Biotech (KNE) Technical Indicators

Jul 23, 2024, 11:19 PM
Name
Value
Implied Action
RSI (14)
49.36
Neutral
STOCH (9,6)
16.19
Buy
STOCHRSI (14)
14.29
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
12.60
Buy
Williams %R
-85.71
Buy
CCI (14)
-63.19
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
19.84
Sell
ROC
-6.67
Sell
Kane Biotech Inc’s (KNE) Relative Strength Index (RSI) is 49.36, creating a Neutral signal.
Kane Biotech Inc’s (KNE) Trend Strength Indicator (ADX) is 12.60, creating a Buy signal.
Kane Biotech Inc’s (KNE) Commodity Channel Index (CCI) is -63.19, creating a Neutral signal.
Kane Biotech Inc’s (KNE) Price Rate of Change (ROC) is -6.67, creating a Sell signal.

FAQ

Is KNE a Buy, Hold, or Sell?
Based on KNE’s technical indicators, KNE is a Buy.
    What is KNE’s RSI (14)?
    KNE’s RSI (14) is 49.36, which suggests KNE is a Neutral.
      What is KNE’s MACD?
      KNE’s MACD is <0.01, which suggests KNE is a Buy.
        What is KNE’s 5-day moving average?
        KNE’s 5-day moving average is 0.14, which suggests KNE is a Sell.
          What is KNE’s 20-day moving average?
          KNE 20-day moving average is 0.14, which suggests KNE is a Sell.
            What is KNE’s 50-day moving average?
            KNE’s 50-day moving average is 0.14, which suggests KNE is a Buy.
              What is KNE’s 200-day moving average?
              KNE’s 200-day moving average is 0.10, which suggests KNE is a Buy.
                What is KNE’s Williams % R (14)?
                KNE’s Williams % R (14) is -85.71, which suggests KNE is a Buy.
                  What is KNE’s CCI (14)?
                  KNE’s CCI (14) is -63.19, which suggests KNE is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis